Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis
Brendan M Weiss, Joseph Hebreo, Daniel V Cordaro, et al.
European Journal of Haematology
|
June 17, 2021
Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019
Laura L Hester, Dina M Gifkins, Kevin M Bellew, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 18, 2016
Melphalan desensitization following immediate hypersensitivity in a patient undergoing conditioning for autologous hematopoietic cell transplantation
Alex Ganetsky, Patricia A Takach, Donna-Marie Lynch, et al.
Blood
|
October 11, 2013
How I treat monoclonal gammopathy of renal significance (MGRS)
Jean-Paul Fermand, Frank Bridoux, Robert A Kyle, et al.
Blood
|
September 9, 2010
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Adam J Waxman, Pamela J Mink, Susan S Devesa, et al.
The Lancet. Haematology
|
December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study
Scott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 18, 2021
Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Andrzej Jakubowiak, Saad Z Usmani, Amrita Krishnan, et al.
JAMA Oncology
|
December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
Adam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
American Journal of Hematology
|
June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathy
Jennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
Journal of Clinical Pharmacology
|
October 28, 2021
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis
Man Melody Luo, Peijuan Penny Zhu, Ivo Nnane, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis
Brendan M Weiss, Joseph Hebreo, Daniel V Cordaro, et al.
European Journal of Haematology
|
June 17, 2021
Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019
Laura L Hester, Dina M Gifkins, Kevin M Bellew, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 18, 2016
Melphalan desensitization following immediate hypersensitivity in a patient undergoing conditioning for autologous hematopoietic cell transplantation
Alex Ganetsky, Patricia A Takach, Donna-Marie Lynch, et al.
Blood
|
October 11, 2013
How I treat monoclonal gammopathy of renal significance (MGRS)
Jean-Paul Fermand, Frank Bridoux, Robert A Kyle, et al.
Blood
|
September 9, 2010
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Adam J Waxman, Pamela J Mink, Susan S Devesa, et al.
The Lancet. Haematology
|
December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study
Scott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 18, 2021
Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Andrzej Jakubowiak, Saad Z Usmani, Amrita Krishnan, et al.
JAMA Oncology
|
December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis
Adam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
American Journal of Hematology
|
June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathy
Jennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
Journal of Clinical Pharmacology
|
October 28, 2021
Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis
Man Melody Luo, Peijuan Penny Zhu, Ivo Nnane, et al.
Page
of 6